Significant Ownership of Lawrence M. Blatt
- Large-stake filing summary
-
- Recent SEC Schedule 13D/G filings for Lawrence M. Blatt focus on large-stake beneficial ownership disclosures and amendments.
- Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
- Manager signature
- /s/ Lawrence M. Blatt - Lawrence M. Blatt, Ph.D.
Large-stake snapshot
1 signal
Manager
Names, identifiers, and filing context for this profile.
1 identity field
Follow Filing Activity
Follow Lawrence M. Blatt with Pro and return when a new Schedule 13D/G filing changes the record on this page.
Pro alert delivery is coming soon and remains tied to source-backed filing changes rather than inferred market advice.
CIK context first
Continue from Lawrence M. Blatt
Significant Ownership of Lawrence M. Blatt
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| ALGS | Aligos Therapeutics, Inc. | Common Stock, par value, $0.0001 per share | 5.6% | $1,694,982 | +$160,880 | 316,228 | +10% | Lawrence M. Blatt | 16 Jun 2026 |
Schedules 13D/G Reported by Lawrence M. Blatt:
| Sym | Target | Class | Ownership | Change | Current shares | Change | Value | Reporting name | Form | Report period | Filing date |
|---|
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.